Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Horm Cancer. 2013 Oct 8;5(1):33–41. doi: 10.1007/s12672-013-0163-9

Figure 2.

Figure 2

Tumor volume and final tumor weight in saline- and Exendin-4-treated rats bearing the Yoshida sarcoma. (A) In TBU rats, tumor volume was comparable between saline- and Exendin-4-treated groups. (B) In TBL rats, tumor volume was significantly lower in Exendin-4-treated animals from Days 17-23, as compared to saline-treated animals (p < 0.05). (C) On the day of sacrifice, tumors were removed and weighed. While no differences were observed between saline- and Exendin-4-treated TBU rats, tumors isolated from Exendin-4-treated TBL rats weighed significantly less than those isolated from saline-treated TBL rats. *p < 0.05